Search Results - Kentarou Kudou
- Showing 1 - 2 results of 2
-
1
Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial by Hiroshi Hoshiai, Yoshifumi Seki, Takeru Kusumoto, Kentarou Kudou, Masataka Tanimoto
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results by Yutaka Osuga, Yoshifumi Seki, Masataka Tanimoto, Takeru Kusumoto, Kentarou Kudou, Naoki Terakawa
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book